Victory Capital Management Inc Selecta Biosciences Inc Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$0.62 - $0.85 $909 - $1,246	-1,467 Reduced 9.74%	13,593 $11,000
Q4 2023 Feb 05, 2024	BUY	$0.67 - $1.35 $1,957 - $3,943	2,921 Added 24.06%	15,060 $10,000
Q3 2023 Nov 06, 2023	BUY	$1.02 - $1.23 $931 - $1,122	913 Added 8.13%	12,139 $12,000
Q2 2023 Jul 27, 2023	SELL	$1.04 - $1.4 $272 - $366	-262 Reduced 2.28%	11,226 $12,000
Q1 2023 May 02, 2023	SELL	$1.15 - $1.89 $541 - $890	-471 Reduced 3.94%	11,488 $15,000
Q4 2022 Feb 09, 2023	SELL	$0.96 - $1.6 $3 - $6	-4 Reduced 0.03%	11,959 $13,000
Q3 2022 Nov 02, 2022	SELL	$1.33 - $2.6 $6,781 - $13,257	-5,099 Reduced 29.89%	11,963 $20,000
Q2 2022 Aug 01, 2022	BUY	$0.67 - $1.4 $695 - $1,453	1,038 Added 6.48%	17,062 $22,000
Q1 2022 May 04, 2022	BUY	$1.23 - $3.31 $4,681 - $12,597	3,806 Added 31.15%	16,024 $12,000
Q4 2021 Feb 07, 2022	SELL	$2.89 - $4.43 $609 - $934	-211 Reduced 1.7%	12,218 $40,000
Q3 2021 Nov 02, 2021	SELL	$3.36 - $4.62 $786 - $1,081	-234 Reduced 1.85%	12,429 $52,000
Q2 2021 Aug 03, 2021	SELL	$2.82 - $5.01 $1,410 - $2,505	-500 Reduced 3.8%	12,663 $53,000
Q1 2021 May 04, 2021	SELL	$2.92 - $5.07 $1,197 - $2,078	-410 Reduced 3.02%	13,163 $60,000
Q4 2020 Feb 01, 2021	SELL	$1.64 - $3.42 $924 - $1,928	-564 Reduced 3.99%	13,573 $41,000
Q3 2020 Nov 09, 2020	BUY	$2.18 - $2.84 $30,818 - $40,149	14,137 New	14,137 $35,000
Q2 2020 Aug 07, 2020	SELL	$1.83 - $4.06 $10,125 - $22,463	-5,533 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$1.5 - $4.52 $1,434 - $4,321	-956 Reduced 14.73%	5,533 $13,000
Q4 2019 Feb 04, 2020	SELL	$1.32 - $2.47 $1,013 - $1,896	-768 Reduced 10.58%	6,489 $23,000
Q3 2019 Nov 12, 2019	BUY	$1.6 - $2.08 $11,611 - $15,094	7,257 New	7,257 $13,000

Others Institutions Holding SELB

# of Institutions

Shares Held

4.67M

Call Options Held

Put Options Held

View Full List

About SELECTA BIOSCIENCES INC

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

More about SELB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account